| Name | Title | Contact Details |
|---|
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Harbinger is a commercial electric vehicle (EV) company on a mission to transform an industry starving for innovation. Harbingers best-in-class team of EV, battery, and drivetrain experts have pooled their deep experience to support the growing demand for medium-duty EVs. Leveraging a foundation of proprietary, in-house developed vehicle technologies designed specifically for commercial vehicles, Harbinger is bringing a first-of-its-kind EV platform to market, priced for zero acquisition premium. Harbinger: familiar form, revolutionary foundation.
evolv is the leader in data & ai business transformation, driving value realization to enable your organizations most strategic initiatives. Our solutions offerings include Strategic Execution, Transformation & Adoption, Data Cloud Modernization, Innovation & Design, and Artificial Intelligence. evolv proactively partners with third parties, including AWS, Microsoft, and Snowflake, with whom we are an Elite Services Partner, to bring the best solutions to our clients. Our team applies a breadth of experience to reveal a wholistic view, optimal use cases, and common mistakes to ultimately achieve accelerated results. evolv has been named to the Inc. 5000 list, a list that recognizes the fastest growing private companies in America. Through 2024, evolv has been the Black Diamond Sponsor for Snowflakes Data 4 Breakfast events in Dallas, Houston, and Austin, as well as the Black Diamond Sponsor for the upcoming Snowflake World Tour in Dallas and Chicago. evolv was a Green Circle Sponsor for the Snowflake Data Cloud Summit in San Fransisco in June 2024, as well as multiple sponsorships with Data.World, ARCET Global, and Matillion.
True Lacrosse is a sports organization founded in 2008 by professional lacrosse players Jake Deane and Mike Gabel, based in Lombard, Illinois. The organization is dedicated to educating and developing young men and women in lacrosse, focusing on creating exceptional athletes while fostering confidence, integrity, and leadership skills. Operating in multiple U.S. states, including Illinois, Colorado, and Michigan, True Lacrosse serves youth players nationwide. The organization emphasizes four core pillars: Passion, Energy, Expertise, and Reps, which guide their training and player development approach. True Lacrosse offers comprehensive training programs that enhance lacrosse skills, game understanding, and athleticism. Their experienced coaching staff, comprised of former professional players, provides valuable insights and support to help players reach their potential and pursue collegiate opportunities. Additionally, True Lacrosse prioritizes player safety by partnering with platforms like HEADCHECK Health to manage concussion risks.